Reversal of arthritis by human monomeric IgA through the receptor-mediated SH2 domain-containing phosphatase 1 inhibitory pathway

Arthritis and Rheumatology

Volumn 67, Issue 7, 2015, Pages 1766-1777

  Rossato, Elisabetta ^a   Ben Mkaddem, Sanae ^a   Kanamaru, Yutaka ^a   Hurtado Nedelec, Margarita ^a   Hayem, Gilles ^b   Descatoire, Véronique ^c   Vonarburg, Cédric ^d   Miescher, Sylvia ^d   Zuercher, Adrian W ^d   Monteiro, Renato C ^a  

^a CENTRE DE RECHERCHE SUR L INFLAMMATION   (France)

^b HÔPITAL AMBROISE PARÉ   (France)

^c BICHAT HOSPITAL   (France)

^d CSL Behring   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; COLLAGEN ANTIBODY; FC ALPHA RECEPTOR TYPE 1; FC RECEPTOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN RECEPTOR; MESSENGER RNA; MONOMERIC IMMUNOGLOBULIN A; PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE SHP 1; UNCLASSIFIED DRUG; FC(ALPHA) RECEPTOR; LEUKOCYTE ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ACTIVATION; CELL INFILTRATION; CONTROLLED STUDY; DRUG INHIBITION; DRUG RECEPTOR BINDING; ENZYME PHOSPHORYLATION; EXPERIMENTAL ARTHRITIS; GENE INDUCTION; IMMUNORECEPTOR TYROSINE BASED ACTIVATION MOTIF; INHIBITORY IMMUNORECEPTOR TYROSINE BASED ACTIVATION MOTIF; LEUKOCYTE; MOUSE; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNOVIAL FLUID; SYNOVIOCYTE; TRANSGENIC MOUSE; WILD TYPE MOUSE; ANIMAL; ARTHRITIS, EXPERIMENTAL; BAGG ALBINO MOUSE; C57BL MOUSE; CASE CONTROL STUDY; CELL CULTURE; CELL LINE; CHEMOTAXIS; DISEASE MODEL; DRUG EFFECTS; FEMALE; GENETICS; HUMAN; IN VITRO STUDY; MALE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYNOVIUM;

ANIMALS; ANTIGENS, CD; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; CELL LINE; CELLS, CULTURED; CHEMOTAXIS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNOGLOBULIN A; IN VITRO TECHNIQUES; LEUKOCYTES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; PHAGOCYTES; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 6; RECEPTORS, FC; SIGNAL TRANSDUCTION; SYNOVIAL MEMBRANE;

EID: 84933060131     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39142     Document Type: Article

References (47)

1. Bakema JE, van Egmond M., The human immunoglobulin A Fc receptor FcαRI: a multifaceted regulator of mucosal immunity. Mucosal Immunol 2011; 4: 612-24.
2. Ben Mkaddem S, Rossato E, Heming N, Monteiro RC., Anti-inflammatory role of the IgA Fc receptor (CD89): from autoimmunity to therapeutic perspectives. Autoimmun Rev 2013; 12: 666-9.
3. Kerr MA., The structure and function of human IgA. Biochem J 1990; 271: 285-96.
4. Monteiro RC, van de Winkel JG., IgA Fc receptors. Annu Rev Immunol 2003; 21: 177-204.
5. Geissmann F, Launay P, Pasquier B, Lepelletier Y, Leborgne M, Lehuen A, et al., A subset of human dendritic cells expresses IgA Fc receptor (CD89), which mediates internalization and activation upon cross-linking by IgA complexes. J Immunol 2001; 166: 346-52.
6. Mazengera RL, Kerr MA., The specificity of the IgA receptor purified from human neutrophils. Biochem J 1990; 272: 159-65.
7. Monteiro RC, Cooper MD, Kubagawa H., Molecular heterogeneity of Fc α receptors detected by receptor-specific monoclonal antibodies. J Immunol 1992; 148: 1764-70.
8. Patry C, Sibille Y, Lehuen A, Monteiro RC., Identification of Fc α receptor (CD89) isoforms generated by alternative splicing that are differentially expressed between blood monocytes and alveolar macrophages. J Immunol 1996; 156: 4442-8.
9. Pleass RJ, Andrews PD, Kerr MA, Woof JM., Alternative splicing of the human IgA Fc receptor CD89. Biochem J 1996; 318: 771-7.
10. Van Egmond M, van Garderen E, van Spriel AB, Damen CA, van Amersfoort ES, van Zandbergen G, et al., FcαRI-positive liver Kupffer cells: reappraisal of the function of immunoglobulin A in immunity. Nat Med 2000; 6: 680-5.
11. Pasquier B, Launay P, Kanamaru Y, Moura IC, Pfirsch S, Ruffie C, et al., Identification of FcαRI as an inhibitory receptor that controls inflammation: dual role of FcRγ ITAM. Immunity 2005; 22: 31-42.
12. Pfirsch-Maisonnas S, Aloulou M, Xu T, Claver J, Kanamaru Y, Tiwari M, et al., Inhibitory ITAM signaling traps activating receptors with the phosphatase SHP-1 to form polarized "inhibisome" clusters. Sci Signal 2011; 4: ra24.
13. Kanamaru Y, Pfirsch S, Aloulou M, Vrtovsnik F, Essig M, Loirat C, et al., Inhibitory ITAM signaling by FcαRI-FcRγ chain controls multiple activating responses and prevents renal inflammation. J Immunol 2008; 180: 2669-78.
14. Feldmann M, Brennan FM, Maini RN., Rheumatoid arthritis. Cell 1996; 85: 307-10.
15. Feldmann M, Brennan FM, Maini RN., Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996; 14: 397-440.
16. Choy EH, Panayi GS., Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 2001; 344: 907-16.
17. McInnes IB, O'Dell JR., State-of-the-art: rheumatoid arthritis [published erratum appears in Ann Rheum Dis 2011;70:399]. Ann Rheum Dis 2010; 69: 1898-906.
18. Liote F, Boval-Boizard B, Weill D, Kuntz D, Wautier JL., Blood monocyte activation in rheumatoid arthritis: increased monocyte adhesiveness, integrin expression, and cytokine release. Clin Exp Immunol 1996; 106: 13-9.
19. Torsteinsdottir I, Arvidson NG, Hallgren R, Hakansson L., Monocyte activation in rheumatoid arthritis (RA): increased integrin, Fcγ and complement receptor expression and the effect of glucocorticoids. Clin Exp Immunol 1999; 115: 554-60.
20. Hatano Y, Kasama T, Iwabuchi H, Hanaoka R, Takeuchi HT, Jing L, et al., Macrophage inflammatory protein 1 alpha expression by synovial fluid neutrophils in rheumatoid arthritis. Ann Rheum Dis 1999; 58: 297-302.
21. Kinne RW, Stuhlmuller B, Burmester GR., Cells of the synovium in rheumatoid arthritis: macrophages. Arthritis Res Ther 2007; 9: 224.
22. Bruhl H, Cihak J, Plachy J, Kunz-Schughart L, Niedermeier M, Denzel A, et al., Targeting of Gr-1+,CCR2+ monocytes in collagen-induced arthritis. Arthritis Rheum 2007; 56: 2975-85.
23. Tanaka D, Kagari T, Doi H, Shimozato T,. Essential role of neutrophils in anti-type II collagen antibody and lipopolysaccharide-induced arthritis. Immunology 2006; 119: 195-202.
24. Terato K, Harper DS, Griffiths MM, Hasty DL, Ye XJ, Cremer MA, et al., Collagen-induced arthritis in mice: synergistic effect of E. Coli lipopolysaccharide bypasses epitope specificity in the induction of arthritis with monoclonal antibodies to type II collagen. Autoimmunity 1995; 22: 137-47.
25. Kagari T, Doi H, Shimozato T,. The importance of IL-1β and TNF-α, and the noninvolvement of IL-6, in the development of monoclonal antibody-induced arthritis. J Immunol 2002; 169: 1459-66.
26. Kagari T, Tanaka D, Doi H, Shimozato T,. Essential role of Fcγ receptors in anti-type II collagen antibody-induced arthritis. J Immunol 2003; 170: 4318-24.
27. Kleinau S, Martinsson P, Heyman B., Induction and suppression of collagen-induced arthritis is dependent on distinct Fcγ receptors. J Exp Med 2000; 191: 1611-6.
28. Campbell IK, Hamilton JA, Wicks IP., Collagen-induced arthritis in C57BL/6 (H-2b) mice: new insights into an important disease model of rheumatoid arthritis. Eur J Immunol 2000; 30: 1568-75.
29. Nandakumar KS, Svensson L, Holmdahl R., Collagen type II-specific monoclonal antibody-induced arthritis in mice: description of the disease and the influence of age, sex, and genes. Am J Pathol 2003; 163: 1827-37.
30. Wipke BT, Wang Z, Nagengast W, Reichert DE, Allen PM., Staging the initiation of autoantibody-induced arthritis: a critical role for immune complexes. J Immunol 2004; 172: 7694-702.
31. McInnes IB, Schett G., The pathogenesis of rheumatoid arthritis. N Engl J Med 2011; 365: 2205-19.
32. Nimmerjahn F, Ravetch JV., Anti-inflammatory actions of intravenous immunoglobulin. Annu Rev Immunol 2008; 26: 513-33.
33. Tha-In T, Bayry J, Metselaar HJ, Kaveri SV, Kwekkeboom J., Modulation of the cellular immune system by intravenous immunoglobulin. Trends Immunol 2008; 29: 608-15.
34. Lee SY, Jung YO, Ryu JG, Kang CM, Kim EK, Son HJ, et al., Intravenous immunoglobulin attenuates experimental autoimmune arthritis by inducing reciprocal regulation of Th17 and Treg cells in an interleukin-10-dependent manner. Arthritis Rheumatol 2014; 66: 1768-78.
35. Launay P, Grossetete B, Arcos-Fajardo M, Gaudin E, Torres SP, Beaudoin L, et al., Fcα receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease): evidence for pathogenic soluble receptor-Iga complexes in patients and CD89 transgenic mice. J Exp Med 2000; 191: 1999-2009.
36. Silvain C, Patry C, Launay P, Lehuen A, Monteiro RC., Altered expression of monocyte IgA Fc receptors is associated with defective endocytosis in patients with alcoholic cirrhosis: potential role for IFN-γ. J Immunol 1995; 155: 1606-18.
37. Liu FT, Bohn JW, Ferry EL, Yamamoto H, Molinaro CA, Sherman LA, et al., Monoclonal dinitrophenyl-specific murine IgE antibody: preparation, isolation, and characterization. J Immunol 1980; 124: 2728-37.
38. Cramer M, Frei R, Sebald A, Mazzoletti P, Maeder W., Stability over 36 months of a new liquid 10% polyclonal immunoglobulin product (IgPro10, Privigen) stabilized with L-proline. Vox Sang 2009; 96: 219-25.
39. Roa M, Paumet F, Le Mao J, David B, Blank U,. Involvement of the ras-like GTPase rab3d in RBL-2H3 mast cell exocytosis following stimulation via high affinity IgE receptors (FcεRI). J Immunol 1997; 159: 2815-23.
40. Terato K, Hasty KA, Reife RA, Cremer MA, Kang AH, Stuart JM., Induction of arthritis with monoclonal antibodies to collagen. J Immunol 1992; 148: 2103-8.
41. Bruhl H, Cihak J, Talke Y, Rodriguez-Gomez M, Hermann F, Goebel N, et al., B-cell inhibition by cross-linking CD79b is superior to B-cell depletion with anti-CD20 antibodies in treating murine collagen-induced arthritis. Eur J Immunol 2014; 45: 705-15.
42. Kawanaka N, Yamamura M, Aita T, Morita Y, Okamoto A, Kawashima M, et al., CD14+,CD16+ blood monocytes and joint inflammation in rheumatoid arthritis. Arthritis Rheum 2002; 46: 2578-86.
43. brightCD16+ monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell population. Arthritis Rheum 2012; 64: 671-7.
44. Blank U, Launay P, Benhamou M, Monteiro RC., Inhibitory ITAMs as novel regulators of immunity. Immunol Rev 2009; 232: 59-71.
45. Nandakumar KS, Holmdahl R., Antibody-induced arthritis: disease mechanisms and genes involved at the effector phase of arthritis. Arthritis Res Ther 2006; 8: 223.
46. Ozaki N, Suzuki S, Ishida M, Harada Y, Tanaka K, Sato Y, et al., Syk-dependent signaling pathways in neutrophils and macrophages are indispensable in the pathogenesis of anti-collagen antibody-induced arthritis. Int Immunol 2012; 24: 539-50.
47. Robinson JJ, Watson F, Bucknall RC, Edwards SW., Role of Fcγ receptors in the activation of neutrophils by soluble and insoluble immunoglobulin aggregates isolated from the synovial fluid of patients with rheumatoid arthritis. Ann Rheum Dis 1994; 53: 515-20.